Core Viewpoint - The commercial health insurance industry is increasingly focusing on insurance products for patients with pre-existing conditions, particularly in the context of disease recurrence insurance, which is expected to see significant growth by 2025 [3][4]. Group 1: Market Trends and Developments - The disease recurrence insurance market has seen new product launches, such as the "Good Effect Insurance" series by Taikang Online, which expanded coverage from breast cancer to include lymphoma and lung cancer [5]. - In 2024, the health insurance premium income reached 977.4 billion yuan, marking an 8.2% growth, but the industry is facing stagnation due to market saturation among healthy individuals [6][7]. - The concept of insuring patients with pre-existing conditions is still relatively new and unclear, with estimates suggesting that the market could be around 50 billion yuan, primarily driven by supplementary medical insurance and high-end medical insurance [9]. Group 2: Product Insights - The most notable products in the disease recurrence insurance category are breast cancer recurrence insurance, which has become the largest single product in this segment, and million medical insurance that covers pre-existing conditions [12]. - The "Zhongminbao" product by Zhong An Insurance achieved rapid success, collecting 1.4 billion yuan in premiums within ten days of launch, indicating strong market demand [12][13]. Group 3: Sales and Distribution Challenges - The primary challenge in selling pre-existing condition insurance lies in distribution channels, as traditional channels are primarily focused on healthy individuals, making it difficult to reach the target demographic [16]. - Collaborations with hospitals are being explored to facilitate access to patients, but these partnerships face regulatory and operational uncertainties [17][18]. - Alternative sales strategies include leveraging pharmaceutical companies' distribution networks, which have shown some success in the market [18]. Group 4: Financial Performance and Risk Management - Currently, the existing pre-existing condition insurance products have not reported losses, but concerns remain regarding the maturity of cost control capabilities [21][22]. - The risk of high claims in million medical insurance products remains a concern, particularly for those that initially relaxed underwriting standards to attract customers [23][24]. - Insurers are employing traditional cost control methods, such as increased premiums and strict underwriting, to manage risks associated with these products [24][25].

Core Viewpoint - The article highlights the recognition of Taikang Online's "Good Effect Insurance - Pink Guardian (Drug-Free Version)" as an innovative insurance product in the field of breast cancer recurrence protection, showcasing the shift in commercial health insurance from "insuring healthy people" to "insuring people's health" [1][3]. Group 1: Product Innovation and Features - Taikang Online launched the "Good Effect Insurance - Pink Guardian" in 2022, providing specialized protection for post-operative breast cancer patients, addressing a gap in the market for insurance covering pre-existing conditions [3][5]. - The upgraded "Drug-Free Version" offers dual protection through reimbursement and lump-sum payment, with a maximum reimbursement of 1 million for recurrence medical expenses and a one-time payment of 50,000 to 500,000 upon diagnosis of recurrence or metastasis [3][4]. - The product includes a dynamic special drug directory covering 58 innovative breast cancer drugs with a 100% reimbursement rate, and it extends medical service networks to 29 quality private specialty institutions and over 1300 DTP pharmacies [4][6]. Group 2: Market Demand and Strategic Positioning - The increasing incidence of breast cancer and the high medical expenses associated with recurrence highlight a significant protection gap in the market, driving demand for comprehensive health insurance solutions [5][6]. - Taikang Online's "Good Effect Insurance" series includes specialized coverage for various cancers, such as thyroid cancer, lung cancer, colorectal cancer, and lymphoma, demonstrating a commitment to addressing the needs of patients with pre-existing conditions [5][6]. - The company aims to create a full-cycle insurance system that integrates medical services, pharmaceutical resources, and financial solutions, enhancing service efficiency and patient care [6]. Group 3: Technological and Resource Integration - Taikang Online leverages its group medical and nursing system to establish a nationwide medical network, providing various medical services and home rehabilitation support [6]. - The company has developed a digital risk control system and an AI customer service platform, enhancing operational efficiency and risk management capabilities [6]. - The integration of commercial insurance with the pharmaceutical industry is seen as a key pathway to solving the protection challenges faced by patients with pre-existing conditions [6].

Core Viewpoint - The new "National Ten Articles" policy released by the State Council aims to enhance the development of the insurance industry over the next 5 to 10 years, focusing on improving health insurance service levels and expanding coverage, which presents new opportunities for the integration of commercial insurance and the pharmaceutical industry [1][2]. Group 1: Policy and Industry Trends - The new policy emphasizes high-quality development in the insurance sector, shifting focus from scale growth to quality, and aims to enhance risk prevention and regulatory oversight [1][4]. - The integration of commercial insurance with the pharmaceutical industry is seen as an inevitable trend, driven by the need for comprehensive health solutions and the potential for significant payment space in commercial insurance [1][4]. Group 2: Company Initiatives and Innovations - On the occasion of its 10th anniversary, Taikang Online hosted a forum to discuss the development paths for insurance products catering to individuals with pre-existing conditions, highlighting the importance of innovation in commercial insurance [1][4]. - Taikang Insurance Group is actively pursuing a comprehensive health ecosystem that addresses the needs of an aging population and the increasing demand for health services, aligning with the "Healthy China" strategy [2][4]. Group 3: Product Development and Market Needs - Taikang Online has developed a product system that covers the entire disease cycle, focusing on cancer patients with innovative insurance products like the "Good Effect Insurance" series, which has undergone multiple iterations to enhance accessibility to innovative drugs [6][7]. - The company aims to transition from being a mere financial payer to a health promoter, addressing the urgent needs of individuals in non-standard health conditions through a triad of good medicine, good drugs, and good services [6][7]. Group 4: Collaborative Ecosystem - The integration of commercial insurance with medical, health insurance, and pharmaceutical sectors is essential for creating a robust industry ecosystem, with various stakeholders emphasizing the need for collaboration to enhance service delivery and efficiency [7]. - Taikang Online is committed to exploring insurance solutions for individuals with pre-existing conditions, aiming to position commercial health insurance as a valuable payment entity within the pharmaceutical industry [7].

Core Insights - The article highlights the launch of a new medical insurance product, "All Insurance," which does not require health declarations and guarantees renewal for five years, addressing the insurance needs of individuals with chronic diseases [1][3][4]. Group 1: Product Features - "All Insurance" allows coverage for general pre-existing conditions, excluding five severe categories, thus enabling individuals with chronic diseases like hypertension and diabetes to obtain insurance [3][4]. - The product offers a coverage limit of 2 million yuan for general medical insurance and 200 million yuan for critical illness medical insurance, with additional benefits for specific treatments [3][4]. - The insurance guarantees renewal for five years, with the maximum renewal age set at 105 years, catering to the needs of the elderly population [4]. Group 2: Market Context - The current market for medical insurance often employs a "yearly throwaway" strategy for individuals with pre-existing conditions, leading to potential coverage gaps [4]. - Approximately 75% of individuals aged 60 and above in China suffer from at least one chronic disease, indicating a significant market for tailored insurance products [4]. Group 3: Service Enhancements - The product includes value-added services such as "one-code payment," "check-up green channel," and "hospitalization green channel," enhancing the overall user experience [6]. - The insurance expands its hospital network to include ten private hospitals, providing users with more healthcare options beyond public hospitals [5]. Group 4: Industry Impact - Waterdrop Insurance aims to redefine the risk boundaries for insurable individuals with chronic conditions, leveraging extensive data to improve underwriting processes [7]. - The collaboration with Deutsche Assistance Life Insurance reflects a commitment to innovation in health insurance, focusing on customer-centric solutions [8].